Toward Ultimate Care for Graves' Hyperthyroidism.
作者信息
Azizi Fereidoun, Abdi Hengameh
机构信息
Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
出版信息
Int J Endocrinol Metab. 2019 Nov 2;18(1):e98255. doi: 10.5812/ijem.98255. eCollection 2020 Jan.
Abstract
摘要
相似文献
1
Toward Ultimate Care for Graves' Hyperthyroidism.迈向格雷夫斯病甲亢的终极治疗
Int J Endocrinol Metab. 2019 Nov 2;18(1):e98255. doi: 10.5812/ijem.98255. eCollection 2020 Jan.
2
Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.Graves 甲亢患者停用抗甲状腺药物后的长期缓解：具有预后价值的参数。
Endocrine. 2019 Feb;63(2):316-322. doi: 10.1007/s12020-018-1785-z. Epub 2018 Oct 17.
3
Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.严重 Graves 眼病患者长期低剂量抗甲状腺药物治疗期间 Graves 甲亢的持续控制。
Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.
4
Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.妊娠期格雷夫斯甲亢的管理：关注母体和胎儿的甲状腺功能，并警惕妊娠期手术甲状腺切除术。
Eur J Endocrinol. 2009 Jan;160(1):1-8. doi: 10.1530/EJE-08-0663. Epub 2008 Oct 10.
5
[Hyperthyroidism in Graves' disease--antithyroid drug treatment].[格雷夫斯病中的甲状腺功能亢进——抗甲状腺药物治疗]
Z Arztl Fortbild Qualitatssich. 1999 Apr;93 Suppl 1:41-5.
6
Antithyroid drug regimen for treating Graves' hyperthyroidism.治疗格雷夫斯甲亢的抗甲状腺药物疗法。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003420. doi: 10.1002/14651858.CD003420.pub3.
7
Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.抗甲状腺药物对 2 型脱碘酶（DIO2）抗体发生的影响，这些抗体参与影响疗效的Graves 病甲亢。
Clin Exp Med. 2019 May;19(2):245-254. doi: 10.1007/s10238-018-00542-7. Epub 2019 Jan 4.
8
[Treatment of Graves' disease--antithyroid drug therapy].[格雷夫斯病的治疗——抗甲状腺药物治疗]
Nihon Rinsho. 1999 Aug;57(8):1846-50.
9
[Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].[放射性碘与手术治疗格雷夫斯病甲亢的对比]
Lijec Vjesn. 2010 Nov-Dec;132(11-12):355-60.
10
Graves' hyperthyroidism in pregnancy.妊娠 Graves 病。
Curr Opin Endocrinol Diabetes Obes. 2019 Oct;26(5):232-240. doi: 10.1097/MED.0000000000000492.
引用本文的文献
1
Efficacy of low-dose methimazole in control of multiple relapses of Graves' hyperthyroidism: a case report.低剂量甲巯咪唑控制格雷夫斯甲亢多次复发的疗效：病例报告
J Med Case Rep. 2021 Apr 23;15(1):189. doi: 10.1186/s13256-021-02788-4.
2
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves' Hyperthyroidism?一场临床辩论：复发性格雷夫斯甲亢的治疗选择是什么？
Int J Endocrinol Metab. 2020 Oct 31;18(4):e108876. doi: 10.5812/ijem.108876. eCollection 2020 Oct.
3
Effect of Aqueous Extract of Leaves and Its Combination with Leaves on Essential Biochemical Parameters of Phenylhydrazine-Induced Anemic Rats.叶水提取物及其与叶的组合对苯肼诱导的贫血大鼠基本生化参数的影响。
J Exp Pharmacol. 2020 Jul 1;12:191-201. doi: 10.2147/JEP.S254003. eCollection 2020.
本文引用的文献
1
Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial.长期甲巯咪唑治疗 Graves 病患者的缓解率增加：一项随机临床试验的结果。
Thyroid. 2019 Sep;29(9):1192-1200. doi: 10.1089/thy.2019.0180. Epub 2019 Aug 28.
2
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.放射性碘治疗与甲状腺功能亢进症患者癌症死亡率的关联。
JAMA Intern Med. 2019 Aug 1;179(8):1034-1042. doi: 10.1001/jamainternmed.2019.0981.
3
Safety of long-term antithyroid drug treatment? A systematic review.长期抗甲状腺药物治疗的安全性？系统评价。
J Endocrinol Invest. 2019 Nov;42(11):1273-1283. doi: 10.1007/s40618-019-01054-1. Epub 2019 May 27.
4
Long-term Methimazole Therapy in Juvenile Graves' Disease: A Randomized Trial.儿童格雷夫斯病的长期甲巯咪唑治疗：一项随机试验。
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2018-3034.
5
2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.2018年欧洲甲状腺协会格雷夫斯甲亢管理指南。
Eur Thyroid J. 2018 Aug;7(4):167-186. doi: 10.1159/000490384. Epub 2018 Jul 25.
6
Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis.长期抗甲状腺药物治疗：系统评价和荟萃分析。
Thyroid. 2017 Oct;27(10):1223-1231. doi: 10.1089/thy.2016.0652. Epub 2017 Sep 15.
7
Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves' disease.格雷夫斯病患儿抗甲状腺药物剂量与不良事件的关系。
Clin Pediatr Endocrinol. 2017 Jan;26(1):1-7. doi: 10.1297/cpe.26.1. Epub 2017 Jan 31.
8
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.2016年美国甲状腺协会甲状腺功能亢进症及其他甲状腺毒症病因的诊断和管理指南。
Thyroid. 2016 Oct;26(10):1343-1421. doi: 10.1089/thy.2016.0229.
9
Antithyroid Drugs-The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study.抗甲状腺药物——美国格雷夫斯病最常见的治疗方法：一项基于全国人口的研究
Thyroid. 2016 Aug;26(8):1144-5. doi: 10.1089/thy.2016.0222. Epub 2016 Jul 5.
10
Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.放射性碘或长期低剂量甲巯咪唑治疗后复发的格雷夫斯病患者的结局
Thyroid. 2015 Dec;25(12):1282-90. doi: 10.1089/thy.2015.0195. Epub 2015 Oct 20.
Zotero 插件